Literature DB >> 19381118

Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD).

Stefano Bellentani1, Mariano Marino.   

Abstract

The authors summarize and update the most recent knowledge in the field of prevalence, natural history and incidence of Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steatohepatitis (NASH). These novel diseases, firstly recognized at the beginning of the second millennium, arose suddenly to the attention of the clinicians, because they are the hepatic expression of the "so-called" metabolic syndrome. Due to the epidemic burden of obesity, diabetes, and metabolic diseases, NAFLD and NASH will become soon probably the most common hepatic disease worldwide, and they surely will keep busy our future young hepatologists.

Entities:  

Mesh:

Year:  2009        PMID: 19381118

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  107 in total

1.  Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.

Authors:  Geraldine J Ooi; Paul R Burton; Arul Earnest; Cheryl Laurie; William W Kemp; Peter D Nottle; Catriona A McLean; Stuart K Roberts; Wendy A Brown
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus.

Authors:  Marco Arrese
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

3.  Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.

Authors:  Shehab M Abd El-Kader; Fadwa M Al-Shreef; Osama H Al-Jiffri
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

Review 4.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

5.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Paul Angulo; David E Kleiner; Sanne Dam-Larsen; Leon A Adams; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Jill C Keach; Heather D Lafferty; Alisha Stahler; Svanhildur Haflidadottir; Flemming Bendtsen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

Review 6.  Non-alcoholic fatty liver disease: a diabetologist's perspective.

Authors:  Joseph M Pappachan; Farrah A Antonio; Mahamood Edavalath; Arjun Mukherjee
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats.

Authors:  L Nikolaenko; Y Jia; C Wang; M Diaz-Arjonilla; J K Yee; S W French; P Y Liu; S Laurel; C Chong; K Lee; Y Lue; W N P Lee; R S Swerdloff
Journal:  Endocrinology       Date:  2013-11-26       Impact factor: 4.736

8.  Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Geraldine J Ooi; Paul R Burton; Lisa Doyle; John M Wentworth; Prithi S Bhathal; Ken Sikaris; Michael A Cowley; Stuart K Roberts; William Kemp; Arul Earnest; Paul E O'Brien; Wendy A Brown
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

9.  The Effect of Chlorella vulgaris Supplementation on Liver En-zymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Mehrangiz Ebrahimi-Mameghani; Soodabeh Aliashrafi; Yousef Javadzadeh; Mohammad AsghariJafarabadi
Journal:  Health Promot Perspect       Date:  2014-07-12

10.  Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients.

Authors:  Alexandra Sima; Romulus Timar; Adrian Vlad; Bogdan Timar; Mihaela Rosu; Isabel Dan; Roxana Sirli; Alina Popescu; Ioan Sporea
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.